Quantcast

Latest Pericardial heart valves Stories

2014-10-20 16:26:56

First Aortic Valve With Removable Stent Provides Performance Similar to Native Valve With the Ease of Implanted Stented Valve AUSTIN, Texas, Oct. 20, 2014 /PRNewswire/ -- On Oct. 16, 2014, surgeons with Cardiothoracic and Vascular Surgeons became the first in Texas to implant the Solo Smart((TM)) Aortic Pericardial Heart Valve. Faraz Kerendi, M.D. and Stephen J. Dewan M.D., cardiothoracic surgeons at Cardiothoracic and Vascular Surgeons, performed the procedure at Heart Hospital of...

2014-09-30 23:04:54

Icahn School of Medicine at Mount Sinai research findings show there was no significant difference in 15-year survival or stroke rates in patients aged between 50 and 69 years who had aortic valve replacement with bioprosthetic valves compared with mechanical valves. New York, NY (PRWEB) September 30, 2014 New Icahn School of Medicine at Mount Sinai research findings published in the October 1 issue of JAMA show there was no significant difference in 15-year survival or stroke rates in...

2014-09-29 12:30:22

JENA, Germany, September 29, 2014 /PRNewswire/ -- Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European CE Mark approval for its dedicated Paravalvular Leak Closure Device, (PLD). The implant is the world's first, specifically designed device indicated for the minimally invasive closure of leaks occurring around artificial aortic and mitral valves. Tor Peters, CEO of the Occlutech Group, commented:...

2014-09-15 16:28:52

No Cases of Moderate or Severe Paravalvular Aortic Regurgitation at One Year MARLBOROUGH, Mass., Sept. 15, 2014 /PRNewswire/ -- New data from the Boston Scientific (NYSE: BSX) clinical trial program of the Lotus(TM) Valve System continue to demonstrate strong performance as a less invasive treatment for patients with severe aortic stenosis who are considered high risk for surgical valve replacement. Data from the REPRISE II clinical trial confirmed safety and effectiveness out to one year,...

2014-07-14 20:21:24

European Launch Means Physicians Can Now Choose From Three Available Valve Sizes To Match Patient Anatomy More Precisely MARLBOROUGH, Mass., July 14, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark and begun the European commercial launch of its new 25 mm Lotus(TM) Transcatheter Aortic Valve Implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes. "Having the 25 mm size allows us to be more precise in selecting the...

2014-06-05 00:21:14

NATICK, Mass., June 4, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has initiated the RESPOND Post Market Registry to assess real world performance of the Lotus(TM) Valve System. The RESPOND Registry will collect data on clinical outcomes and device performance in 1,000 patients implanted at 50 centers around the world. Three patients enrolled in the RESPOND Registry thus far have been successfully implanted with the Lotus Valve System. Dr. Nicolas Van Mieghem and...


Word of the Day
ween
  • To think; to imagine; to fancy.
  • To be of opinion; have the notion; think; imagine; suppose.
The word 'ween' comes from Middle English wene, from Old English wēn, wēna ("hope, weening, expectation"), from Proto-Germanic *wēniz, *wēnōn (“hope, expectation”), from Proto-Indo-European *wen- (“to strive, love, want, reach, win”).
Related